Jia F, Fellner A, Kumar KR (2022) Monogenic parkinson’s disease: Genotype, phenotype, pathophysiology, and genetic testing. Genes 13(3):471

Article  PubMed  PubMed Central  CAS  Google Scholar 

Koros C, Bougea A, Simitsi AM, Papagiannakis N, Angelopoulou E, Pachi I et al (2023) The landscape of monogenic Parkinson’s disease in populations of Non-European ancestry: a narrative review. Genes 14(11):2097

Article  PubMed  PubMed Central  CAS  Google Scholar 

Blauwendraat C, Nalls MA, Singleton AB (2020) The genetic architecture of Parkinson’s disease. Lancet Neurol 19(2):170–178

Article  PubMed  CAS  Google Scholar 

Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D et al (2019) Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: a meta-analysis of genome-wide association studies. Lancet Neurol 18(12):1091–1102

Article  PubMed  PubMed Central  CAS  Google Scholar 

Keller MF, Saad M, Bras J, Bettella F, Nicolaou N, Simon-Sanchez J et al (2012) Using genome-wide complex trait analysis to quantify “missing heritability” in Parkinson’s disease. Hum Mol Genet 21(22):4996–5009

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kim JJ, Vitale D, Otani DV, Lian MM, Heilbron K, 23andMe Research Team et al (2024) Multi-ancestry genome-wide association meta-analysis of parkinson’s disease. Nat Genet 56(1):27–36. https://doi.org/10.1038/s41588-023-01584-8

Article  PubMed  CAS  Google Scholar 

Fernández-Santiago R, Sharma M (2022) What have we learned from genome-wide association studies (GWAS) in Parkinson’s disease? Ageing Res Rev 79:101648

Article  PubMed  Google Scholar 

Wirdefeldt K, Gatz M, Reynolds CA, Prescott CA, Pedersen NL (2011) Heritability of Parkinson disease in Swedish twins: a longitudinal study. Neurobiol Aging 32(10):1923.e1-1923.e8

Article  PubMed  Google Scholar 

Cisterna-Garcia A, Bustos BI, Bandres-Ciga S, Leal TP, Sarihan EI, Jok C et al (2024) Genome-wide epistasis analysis reveals significant epistatic signals associated with Parkinson’s disease risk. Online ahead of print

Fang G, Wang W, Paunic V, Heydari H, Costanzo M, Liu X et al (2019) Discovering genetic interactions bridging pathways in genome-wide association studies. Nat Commun 10(1):4274

Article  PubMed  PubMed Central  Google Scholar 

Wang K, Li M, Hakonarson H (2010) Analysing biological pathways in genome-wide association studies. Nat Rev Genet 11(12):843–854

Article  PubMed  CAS  Google Scholar 

Berthold N, Gaudieri S, Hood S, Tschochner M, Miller AL, Jordan J et al (2024) Nanopore sequencing as a novel method of characterising anorexia nervosa risk loci. BMC Genomics 25(1):1262

Article  PubMed  PubMed Central  CAS  Google Scholar 

Schumacher-Schuh AF (2022) Underrepresented populations in Parkinson’s genetics research: current landscape and future directions. Mov Dis 37(8):1593–1604

Article  Google Scholar 

Atkinson EG, Maihofer AX, Kanai M, Martin AR, Karczewski KJ, Santoro ML et al (2021) Tractor uses local ancestry to enable the inclusion of admixed individuals in GWAS and to boost power. Nat Genet 53(2):195–204

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ohnmacht J, May P, Sinkkonen L, Krüger R (2020) Missing heritability in Parkinson’s disease: The emerging role of non-coding genetic variation. J Neural Transm 127(5):729–748

Article  PubMed  Google Scholar 

Zabetian CP, Mata IF (2017) On behalf of the Latin American research consortium on the genetics of PD (LARGE-PD). LARGE-PD: examining the genetics of Parkinson’s disease in Latin America. Mov Dis 32(9):1330–1

Article  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 10(1):89

Article  PubMed  PubMed Central  Google Scholar 

Sohani ZN, Meyre D, De Souza RJ, Joseph PG, Gandhi M, Dennis BB et al (2015) Assessing the quality of published genetic association studies in meta-analyses: the quality of genetic studies (Q-Genie) tool. BMC Genet 16(1):50

Article  PubMed  PubMed Central  Google Scholar 

Santos-Rebouças CB, Gonçalves AP, Dos Santos JM, Abdala BB, Motta LB, Laks J et al (2017) rs3851179 Polymorphism at 5′ to the PICALM gene is associated with alzheimer and Parkinson diseases in Brazilian population. Neuromol Med 19(2–3):293–299

Article  Google Scholar 

Leal TP, Shiloh C, Jennifer N, French-Kwawu, et al (2023) X‐Chromosome association study in Latin American cohorts identifies New Loci in Parkinson’s disease. Mov Disord 38(9):1625–1635

Sarihan EI, Pérez-Palma E, Niestroj L, Loesch D, Inca-Martinez M, Horimoto ARVR et al (2021) Genome-wide analysis of copy number variation in Latin American parkinson’s disease patients. Mov Disord 36(2):434–441

Article  PubMed  CAS  Google Scholar 

Salas-Leal AC, Sandoval-Carrillo A, Romero-Gutiérrez E, Castellanos-Juárez FX, Méndez-Hernández EM, La Llave-León O et al (2019) rs3764435 associated with Parkinson’s disease in Mexican mestizos: Case-control study reveals protective effects against disease development and cognitive impairment. Front Neurol 9(10):1066

Article  Google Scholar 

Romero-Gutiérrez E, Vázquez-Cárdenas P, Moreno-Macías H, Salas-Pacheco J, Tusié-Luna T, Arias-Carrión O (2021) Differences in MTHFR and LRRK2 variant’s association with sporadic Parkinson’s disease in Mexican Mestizos correlated to Native American ancestry. npj Parkinsons Dis 7(1):13

Article  PubMed  PubMed Central  Google Scholar 

García S, López-Hernández L, Dávila-Maldonado L, Cuevas-García C, Gallegos-Arreola M, Alcaraz-Estrada S, et al (2019) Association of mitochondrial variants A4336G of the tRNAGln gene and 8701G/A of the MT-ATP6 gene in Mexicans Mestizos with Parkinson disease. fn 57(4):335–339

Ramírez Jirano LJ, Ruiz Sandoval JL, Jiménez Gil FJ, Ramírez Vega J, Vargas Frutos E, Gallegos Arreola MP (2007) Frecuencia del polimorfismo IVS4+66A-G en el gen alfa-sinucleína en pacientes con enfermedad de Parkinson del noroccidente de México. RevNeurol 44(01):15

Salas-Leal AC, Salas-Pacheco SM, Gavilán-Ceniceros JAP, Castellanos-Juárez FX, Méndez-Hernández EM, La Llave-León O et al (2021) α-syn and SNP rs356219 as a potential biomarker in blood for Parkinson’s disease in Mexican Mestizos. Neurosci Lett 754:135901

Article  PubMed  CAS  Google Scholar 

Gallegos-Arreola MP, Figuera LE, Ortiz GG, Jiménez-Gil FJ, Ramírez-Vega J, Ruíz-Sandoval JL et al (2009) Apolipoprotein E genotypes in Mexican patients with Parkinson’s disease. Dis Markers 27(5):225–230

Article  PubMed  PubMed Central  CAS  Google Scholar 

Marca V, Acosta O, Torres L, Ortega O, Cornejo-Olivas M, Lindo-Samanamud S et al (2013) Asociación entre el polimorfismo genético de la apolipoproteína E (ApoE) y la enfermedad de Parkinson. An Fac med 74(3):169

Article  Google Scholar 

Baltus THL, Morelli NR, De Farias CC, Trugilo KP, Okuyama NCM, De Oliveira KB, et al (2021) Association of -94 ATTG insertion/deletion NFkB1 and c.*126G>A NFkBIA genetic polymorphisms with oxidative and nitrosative stress biomarkers in Brazilian subjects with Parkinson’s Disease. Neurosci Lett 740:135487

Ruiz-Sánchez E, Yescas P, Rodríguez-Violante M, Martínez-Rodríguez N, Díaz-López JN, Ochoa A, et al (2017) Association of polymorphisms and reduced expression levels of the NR4A2 gene with Parkinson’s disease in a Mexican population. J Neurol Sci 379:58–63

García S, Coral-Vázquez RM, Gallegos-Arreola MP, Montes-Almanza LÁ, Canto P, García-Martínez FA et al (2015) Association of the rs1801133 variant in the MTHFR gene and sporadic Parkinson’s disease. Folia Neuropathol 1:24–28

Loesch DP, Horimoto ARVR, Heilbron K, Sarihan EI, Inca-Martinez M, Mason E et al (2021) Characterizing the genetic architecture of Parkinson’s disease in Latinos. Ann Neurol 90(3):353–365

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sesar A, Cacheiro P, López-López M, Camiña-Tato M, Quintáns B, Monroy-Jaramillo N, et al (2016) Synaptotagmin XI in Parkinson’s disease: new evidence from an association study in Spain and Mexico. J Neurol Sci 362:321–325

Velez-Pardo C, Lorenzo-Betancor O, Jimenez-Del-Rio M, Moreno S, Lopera F, Cornejo-Olivas M et al (2019) The distribution and risk effect of GBA variants in a large cohort of PD patients from Colombia and Peru. Parkinsonism Relat Disord 63:204–208

Article  PubMed  PubMed Central  Google Scholar 

Dávila Ortiz De Montellano DJ, Rodríguez Violante M, Fresán A, Monroy Jaramillo N, Yescas Gómez P (2016) Frecuencia de polimorfismos de nucleótido único y haplotipos de alfa-sinucleína asociados con la enfermedad de Parkinson esporádica en población mexicana. RevNeurol 63(08):345

Article  Google Scholar 

García S, Chavira-Hernández G, Gallegos-Arreola MP, Dávila-Maldonado L, García Martínez F, Montes Almanza LA et al (2016) The rs3857059 variant of the SNCA gene is associated with Parkinson’s disease in Mexican Mestizos. Arq Neuro-Psiquiatr 74(6):445–449

Article  Google Scholar 

Brolin K, Bandres-Ciga S, Leonard H, Makarious MB, Blauwendraat C, Mata IF, et al (2022) RIC3 variants are not associated with Parkinson’s disease in large European, Latin American, or East Asian cohorts. Neurobiol Aging 109:264–268

Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease

Goetz CG, Tilley BC, Shaftman SR, et al (2008) Movement disorder society-sponsored revision of the Unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129–2170

Wilson DM III, Cookson MR, den Bosch LV, Zetterberg H, Holtzman DM (2023) Hallmarks of neurodegenerative diseases. Cell 16(186):693–714

Article  Google Scholar